|Bid||1,426.20 x 0|
|Ask||1,426.60 x 0|
|Day's Range||1,410.60 - 1,434.20|
|52 Week Range||1,190.80 - 1,528.80|
|Beta (5Y Monthly)||0.40|
|PE Ratio (TTM)||13.71|
|Earnings Date||Oct 27, 2021|
|Forward Dividend & Yield||0.80 (5.57%)|
|Ex-Dividend Date||May 20, 2021|
|1y Target Est||N/A|
In this episode of Influencers, Andy is joined by 23andMe co-founder & CEO, Anne Wojcicki, as they discuss the benefits of DNA testing, concerns over privacy in the healthcare industry, and the future of medicine.
23andMe CEO Anne Wojcicki joins 'Influencers with Andy Serwer' to weigh in on the Elizabeth Holmes saga and why it had ‘no’ impact on consumer trust of 23andMe.
(Bloomberg) -- A Centers for Disease Control and Prevention advisory panel backed booster shots of the Pfizer Inc.-BioNTech SE vaccine for people ages 65 and older in the U.S. People over 18 with weakened immune systems were also recommended for an extra dose.Most Read from BloombergSchool Reopenings Falter as U.S. Kids Near 1 Million Covid CasesIstanbul Turns Taps on Old Fountains, Joining Global Push for Free DrinksIn Paris, the Wrapped Arc de Triomphe Is a Polarizing PackageHow the Child Care